David S. Yee, MD, MPH

Associate Dean of Clinical Medicine
Associate Clinical Professor of Urology and Urologic Oncology

Phone: (916) 686-7300
Fax: (916) 686-7310

David Yee, MD, MPH


  • BS, University of California, Davis
  • MPH, University of California, Berkeley School of Public Health
  • MD, University of California, Davis School of Medicine
  • General Surgery Internship, University of California, Irvine Medical Center
  • Urologic Surgery, University of California, Irvine Medical Center
  • Robotic Surgery Fellowship, University of California, Irvine Medical Center
  • Urologic Oncology Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY


Dr. David Yee is the Associate Dean of Clinical Medicine at California Northstate University College of Medicine and Associate Clinical Professor of Urology and Urologic Oncology. Passionate about medical education and training the next generation of physician leaders, he serves as a mentor and role model to our medical students.

Dr. Yee is a sixth generation Californian and physician, and his family ties to Northern California are part of the region’s history. His great-great-great grandfather, Dr. Yee Fung Cheung, was an herbal doctor in the Gold Country, and his store in Fiddletown, California is a state landmark. In 1862, Dr. Yee brewed an herbal remedy that cured California First Lady Jane Stanford of a severe pulmonary illness.

Dr. Yee graduated Phi Beta Kappa as an undergraduate and completed medical school from the University of California, Davis. During medical school, he obtained a Master of Public Health from the University of California, Berkeley pursuing his interest in cancer epidemiology and healthcare policy. He then completed his residency in urologic surgery and served on faculty at the University of California, Irvine, where he also completed his fellowship training in robotic surgery. In addition, Dr. Yee completed fellowship training in urologic oncology and was a clinical instructor at Memorial Sloan-Kettering Cancer Center in New York.

Currently, he is the Director of the Urology and Genitourinary Oncology Services at Sutter Roseville Medical Center and serves as a principal investigator of prostate cancer clinical trials at Sutter Health. He is also the Secretary of the Board of Trustees at Sutter Roseville Medical Center Foundation and is on the Board of Directors of Sutter Medical Group. An advocate for legislation that places patients first and promotes healthcare to underserved communities, he serves as the Secretary/Treasurer of the Placer-Nevada County Medical Society and as a California Medical Association Delegate.

Recognized for his leadership and research endeavors in the field of urology and urologic oncology, he has published over thirty peer-reviewed journal articles and serves as a journal reviewer for his field’s leading journals. He also serves on clinical faculty at the University of California, Davis School of Medicine and is a physician mentor at the Paul Hom Asian Clinic in Sacramento. For his service and leadership in the medical profession, he was selected as an American Urological Association International Volunteers in Urology scholar and traveled to Vietnam and Thailand as a visiting surgeon.

Appointed by Governor Newsom, he serves as Commissioner on the California Commission on Asian and Pacific Islander American Affairs. He also received the President’s Volunteer Service Award for his service that has made an impact on communities throughout the nation and for inspiring others. Recently, he was named as an Asian American and Pacific Islander Change Maker by the Sacramento Bee for leading positive transformations in the community and enriching lives in the Sacramento region.

Selected Publication

  1. Lowrance WT, Elkin EB, Jacks LM, Yee DS, Scardino PT and Eastham JA. Locally advanced prostate cancer: a population-based study of treatment patterns. BJU Int 2011 Nov 15.
  2. Lowrance WT, Eastham JA, Yee DS, Laudone VP, Denton B, Scardino PT and Elkin EB. Costs of medical care after open or minimally invasive prostate cancer surgery: A population-based analysis. Cancer 2011 Oct 24.
  3. Yee DS, Ishill NM, Lowrance WT, Herr HW, Elkin EB. Ethnic differences in bladder cancer survival. Urology 2011 Sep;78(3):544-9.
  4. Feifer AH, Lowrance WT, Denton B, Jacks L, Yee DS, Coleman JA, Laudone V, Scardino PT and Eastham JA. Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy. Cancer 2011 Sep 1;117(17):3933-42.
  5. Adamy A, Lowrance WT, Yee DS, Chong KT, Bernstein M, Tickoo SK, Coleman JA and Russo P. Renal oncocytosis: management and clinical outcomes. J Urol 2011 Jan 14.
  6. Adamy A, Yee DS, Matsushita K, Maschino A, Cronin A, Vickers A, Guillonneau B, Scardino PT and Eastham JA. Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer. J Urol 2011 Feb;185(2):477-82.
  7. Yee DS, Shariat SF, Lowrance WT, Maschino AC, Savage CJ, Cronin AM, Scardino PT and Eastham JA. Prognostic significance of lymphovascular invasion in radical prostatectomy specimens. BJU Int 2010 Nov 2.
  8. Yee DS, Tang Y, Li X, Liu Z, Guo Y, Ghaffar S, McQueen P, Dash A, Xie J, Simoneau AR, Hoang BH and Zi X. The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition. Molecular Cancer 2010 Jun 23;9:162.
  9. Lowrance WT, Yee DS, Savage MS, Cronin AM, O’Brien MF, Donat SM, Vickers A and Russo P. Complications after radical and partial nephrectomy as a function of age. J Urol 2010 May;183(5):1725-30.
  10. Yee DS, Shariat SF, Lowrance WT, Sterbis JR, Vora KC, Bochner BH, Donat SM, Herr HW, Dalbagni G and Sandhu JS. Impact of previous radiotherapy for prostate cancer on clinical outcomes of bladder cancer patients. J Urol 2010 May;183(5):1751-6.
  11. Lowrance WT, Elkin EB, Jacks LM, Yee DS, Jang TL, Laudone VP, Guillonneau BD, Scardino PT and Eastham JA. Comparative effectiveness of different surgical treatments for prostate cancer: a population-based analysis of postoperative outcomes. J Urol 2010 Apr;183(4):1366-72.
  12. Yee DS, Katz D, Godoy G, Nogueira L, Chong KT, Kaag M and Coleman JA. Extended pelvic lymph node dissection in robotic assisted laparoscopic radical prostatectomy. Urology 2010 Feb 15.
  13. Katz D, Yee DS, Godoy G, Nogueira L, Chong KT, and Coleman JA. Lymph node dissection during robotic-assisted laparoscopic prostatectomy: comparison of lymph node yield and clinical outcomes when including common iliac nodes with standard template dissection. BJU Int Jan 19.
  14. Lowrance WT, Yee DS, Cronin AM, Maschino AC, Bernstein M Thompson RH and Russo P. Development in the surgical management of sporadic synchronous bilateral renal tumors. BJU Int Sep 14.
  15. Yee DS, Narula N, Amin MB, Skarecky DW and Ahlering TE. Robot assisted radical prostatectomy: current evaluation of surgical margins in clinically low, intermediate and high risk prostate cancer. J Endourol Jul 10.
  16. Yee DS, Lowrance WT, Eastham JA, Maschino AC, Cronin AM and Rabbani F. Long-term followup of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial. BJU Int 2009 Jul 8.
  17. Lowrance WT, Thompson RH, Yee DS, Kaag M, Donat SM, Russo P. Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int 2009 Jul 6.
  18. Yee DS, Perer E and Hovey RM. Intravesical migration of an intrauterine device managed with holmium laser lithotripsy. Curr Urol 2008; 2:100-102.
  19. Tyson D, Ornstein DK, Inokuchi J, Narula N, Yee DS, Skarecky DW and Lau A. Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells. Int J Cancer 2009 Jan 1; 124(1):68-74.
  20. Yee DS and Shanberg AM. Surgical management of bilateral ureteral endometriosis. Int Urol Nephrol 2006; 38:469-71.